Tag:
basal cell carcinoma
Latest Headlines
Latest Headlines
Roche wins landmark approval for targeted cancer drug vismodegib
Roche ( $RHHBY ) and Genentech won a landmark approval for the cancer drug vismodegib today. After gaining significant efficacy data from a Phase II study on basal cell carcinoma, the drug giant not
Roche rushes new cancer drug to regulators on Ph2 data
When Roche tried to gain an approval to use T-DM1 against breast cancer based on mid-stage results from a single-arm study, the FDA sent its regulatory team packing--refusing to even review the
Roche preps vismodegib app with "profound" efficacy data
Armed with positive data from a pivotal Phase II trial, Lexington, MA-based Curis is waiting for its partner Roche to begin its long-awaited pitch to gain FDA approval for a new treatment for
Roche preps vismodegib app after Ph2 skin cancer success
Roche and Genentech have posted a fresh set of promising mid-stage data on vismodegib , a cancer drug it's collaborating on with Lexington, MA-based Curis. In what investigators describe as a pivotal
